• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氮芥作为类风湿关节炎的诱导治疗:临床和免疫学效应

Nitrogen mustard as induction therapy for rheumatoid arthritis: clinical and immunologic effects.

作者信息

Danao T, Ropos T, Wilke W, Segal A, Calabrese L, Valenzuela R, Gragg L, Clough J

机构信息

Department of Rheumatic and Immunologic Disease, Cleveland Clinic Foundation, Ohio 44195.

出版信息

J Rheumatol. 1992 Nov;19(11):1683-6.

PMID:1491386
Abstract

We treated 5 patients diagnosed with rheumatoid arthritis (RA) with nitrogen mustard (HN2) and monitored clinical and immunologic variables. HN2, 0.3 mg/kg ideal body weight was given over 7 days. Disease activity and immune function were monitored during and after treatment. Duration of morning stiffness (p = 0.0044), joint count (p = 0.0140), and assessment of pain (p = 0.0264) and function (p = 0.0057) improved by Day 6. T lymphocytes (p = 0.0060), especially T memory cells (CD4CD29; p = 0.0017) fell dramatically. HN2 is effective for rapidly gaining control of active RA. This effect is T cell specific.

摘要

我们用氮芥(HN2)治疗了5例诊断为类风湿性关节炎(RA)的患者,并监测了临床和免疫学变量。以0.3 mg/kg理想体重的氮芥持续给药7天。在治疗期间及治疗后监测疾病活动和免疫功能。到第6天时,晨僵持续时间(p = 0.0044)、关节计数(p = 0.0140)以及疼痛评估(p = 0.0264)和功能评估(p = 0.0057)均有所改善。T淋巴细胞(p = 0.0060),尤其是T记忆细胞(CD4CD29;p = 0.0017)显著减少。氮芥对于迅速控制活动期类风湿性关节炎有效。这种作用具有T细胞特异性。

相似文献

1
Nitrogen mustard as induction therapy for rheumatoid arthritis: clinical and immunologic effects.氮芥作为类风湿关节炎的诱导治疗:临床和免疫学效应
J Rheumatol. 1992 Nov;19(11):1683-6.
2
Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.一项开放标签研究,旨在评估类风湿关节炎患者中英夫利昔单抗的安全性及临床获益起效时间。
J Rheumatol. 2002 Apr;29(4):667-77.
3
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.高剂量与低剂量氟达拉滨治疗重度难治性类风湿关节炎患者的疗效比较
J Rheumatol. 1998 Sep;25(9):1694-704.
4
Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.临床中类风湿性关节炎疾病状态的评估与记录:哪些变量最能预测治疗变化。
J Rheumatol. 2001 Jul;28(7):1712-7.
5
What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?哪些因素会影响类风湿性关节炎患者的功能能力?这些因素会随时间变化吗?
Rheumatology (Oxford). 2005 Sep;44(9):1181-5. doi: 10.1093/rheumatology/keh707. Epub 2005 Jun 21.
6
High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.高剂量化疗与造血干细胞移植:类风湿关节炎患者及风湿病学家的治疗偏好研究
J Rheumatol. 2002 Aug;29(8):1653-8.
7
Self-assessment of disease activity by patients with rheumatoid arthritis.类风湿关节炎患者对疾病活动度的自我评估。
J Rheumatol. 1996 Sep;23(9):1531-8.
8
Pulsed suppressive treatment in rheumatoid arthritis: intravenous methylprednisolone and nitrogen mustard.类风湿关节炎的脉冲式抑制治疗:静脉注射甲基强的松龙和氮芥。
J Rheumatol. 1990 Jul;17(7):893-9.
9
A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.对类风湿性关节炎患者进行的1986 - 1996年10年前瞻性随访。
J Rheumatol. 2001 Nov;28(11):2409-15.
10
Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.调节性CD4 + T细胞亚群的表达降低与类风湿关节炎中的Th1/Th2平衡及疾病严重程度相关。
Arthritis Rheum. 2000 Mar;43(3):617-27. doi: 10.1002/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B.